• 1
    Westermann CJ, Rosina AF, De Vries V, de Coteau PA. The prevalence and manifestations of hereditary hemorrhagic telangiectasia in the Afro-Caribbean population of the Netherlands Antilles: a family screening. Am J Med Genet A2003; 116A: 3248.
  • 2
    Shovlin CL. Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Rev2010; 24: 20319.
  • 3
    Krings T, Ozanne A, Chng SM, Alvarez H, Rodesch G, Lasjaunias PL. Neurovascular phenotypes in hereditary haemorrhagic telangiectasia patients according to age. Review of 50 consecutive patients aged 1 day–60 years. Neuroradiology2005; 47: 71120.
  • 4
    Faughnan ME, Palda VA, Garcia-Tsao G, et al.International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet2011; 48: 7387.
  • 5
    Ricard N, Bidart M, Mallet C, et al.Functional analysis of the BMP9 response of ALK1 mutants from HHT2 patients: a diagnostic tool for novel ACVRL1 mutations. Blood2010; 116: 160412.
  • 6
    ten Dijke P, Goumans MJ, Pardali E. Endoglin in angiogenesis and vascular diseases. Angiogenesis2008; 11: 7989.
  • 7
    Morgan T, McDonald J, Anderson C, et al.Intracranial hemorrhage in infants and children with hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome). Pediatrics2002; 109: E12.
  • 8
    Berg J, Porteous M, Reinhardt D, et al.Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations. J Med Genet2003; 40: 58590.
  • 9
    Letteboer TG, Mager JJ, Snijder RJ, et al.Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia. J Med Genet2006; 43: 3717.
  • 10
    Easey AJ, Wallace GM, Hughes JM, Jackson JE, Taylor WJ, Shovlin CL. Should asymptomatic patients with hereditary haemorrhagic telangiectasia (HHT) be screened for cerebral vascular malformations? Data from 22,061 years of HHT patient life. J Neurol Neurosurg Psychiatry2003; 74: 7438.
  • 11
    Leung KM, Agid R, terBrugge K. Spontaneous regression of a cerebral arteriovenous malformation in a child with hereditary hemorrhagic telangiectasia. Case report. J Neurosurg2006; 105: 42831.
  • 12
    Krings T, Chng SM, Ozanne A, Alvarez H, Rodesch G, Lasjaunias PL. Hereditary haemorrhagic telangiectasia in children. Endovascular treatment of neurovascular malformations. Results in 31 patients. Interv Neuroradiol2005; 11: 1323.
  • 13
    Reitz M, Schmidt NO, Vukovic Z, et al.How to deal with incompletely treated AVMs: experience of 67 cases and review of the literature. Acta Neurochir Suppl2011; 112: 1239.
  • 14
    Mohr JP, Moskowitz AJ, Stapf C, et al.The ARUBA trial: current status, future hopes. Stroke2010; 41: e53740.
  • 15
    Fullerton HJ, Achrol AS, Johnston SC, et al.Long-term hemorrhage risk in children versus adults with brain arteriovenous malformations. Stroke2005; 36: 2099104.
  • 16
    Ellis MJ, Armstrong D, Vachhrajani S, et al.Angioarchitectural features associated with hemorrhagic presentation in pediatric cerebral arteriovenous malformations. J Neurointerv Surg2012. Mar 13 [Epub ahead of print].
  • 17
    Krings T, Geibprasert S, Terbrugge K. Classification and endovascular management of pediatric cerebral vascular malformations. Neurosurg Clin N Am2010; 21: 46382.
  • 18
    Crawford PM, West CR, Chadwick DW, Shaw MD. Arteriovenous malformations of the brain: natural history in unoperated patients. J Neurol Neurosurg Psychiatry1986; 49: 110.
  • 19
    Graf CJ, Perret GE, Torner JC. Bleeding from cerebral arteriovenous malformations as part of their natural history. J Neurosurg1983; 58: 3317.
  • 20
    Guidetti B, Delitala A. Intracranial arteriovenous malformations. Conservative and surgical treatment. J Neurosurg1980; 53: 14952.
  • 21
    Fung E, Ganesan V, Cox TS, Chong WK, Saunders DE. Complication rates of diagnostic cerebral arteriography in children. Pediatr Radiol2005; 35: 11747.
  • 22
    Bernhardt BA, Zayac C, Trerotola SO, Asch DA, Pyeritz RE. Cost savings through molecular diagnosis for hereditary hemorrhagic telangiectasia. Genet Med2012; 14: 60410.
  • 23
    Cohen JH, Faughnan ME, Letarte M, Vandezande K, Kennedy SJ, Krahn MD. Cost comparison of genetic and clinical screening in families with hereditary hemorrhagic telangiectasia. Am J Med Genet A2005; 137: 15360.
  • 24
    Borry P, Stultiens L, Nys H, Cassiman JJ, Dierickx K. Presymptomatic and predictive genetic testing in minors: a systematic review of guidelines and position papers. Clin Genet2006; 70: 37481.
  • 25
    Bharatha A, Faughnan ME, Kim H, et al.Brain arteriovenous malformation multiplicity predicts the diagnosis of hereditary hemorrhagic telangiectasia: quantitative assessment. Stroke2012; 43: 728.